A dose selection study evaluating the safety and immunogenicity of 2 different doses of a new TB vaccine, MVA85A, in healthy volunteers who have previously been vaccinated with BCG

Trial Profile

A dose selection study evaluating the safety and immunogenicity of 2 different doses of a new TB vaccine, MVA85A, in healthy volunteers who have previously been vaccinated with BCG

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Apr 2008

At a glance

  • Drugs MVA 85A (Primary)
  • Indications Tuberculosis
  • Focus Adverse reactions
  • Most Recent Events

    • 09 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top